Research interests

DK: Stereotaksi af levermetastaser. GI-strålebehandling. Udvikling af klinisk brug af MR-linac.

UK: Stereotaxis of liver metastases. GI-radiation treatment. Development of clinical use of MR-linac. 

Workgroups

• IP7 - Upper gastrointestinal
• IP8 - Liver and gall bladder
• IP15 - Oligometastatic disease

Publications

• Stick LB, Vogelius IR, Risum S, Josipovic M. Intrafractional fiducial marker position variations in stereotactic liver radiotherapy during voluntary deep inspiration breath-hold Br J Radiol. 2020 Dec 1;93(1116):20200859. 2020
• Grønberg BH, Killingberg KT, Fløtten Ø, Brustugun OT, Hornslien K, Madebo T, Langer SW, Schytte T, Nyman J, Risum S, Tsakonas G, Engleson J, Halvorsen TO High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial Lancet Oncol. 2021 Mar;22(3):321-331 2021
• Tascón-Vidarte JD, Stick LB, Josipovic M, Risum S, Jomier J, Erleben K, Vogelius IR, Darkner S Accuracy and consistency of intensity-based deformable image registration in 4DCT for tumor motion estimation in liver radiotherapy planning PLoS One. 2022 Jul 8;17(7):e0271064 2022
• Killingberg KT, Halvorsen TO, Fløtten Ø, Brustugun OT, Langer SW, Nyman J, Hornslien K, Madebo T, Schytte T, Risum S, Tsakonas G, Engleson J, Grønberg BH Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer Lung Cancer. 2022 Apr;166:49-57 2022